VSee Health exchanges $612K note for 941K shares and enters $25M ELOC

VSEE HEALTH, INC.

Exchanged $611,878.22 promissory note for 941,352 common shares; note cancelled.
Secured $25M equity line of credit (ELOC) via directed stock purchase agreement; 36-month term.
ELOC pricing: 96% of 10-day low VWAP (94% if price below $1.00); expanded purchase up to $5M.
Sales capped at 19.9% of outstanding shares; proceeds for working capital and corporate purposes.
Both transactions with accredited institutional investors; unregistered under Sections 3(a)(9) and 4(a)(2).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.